Market Tracker

04/23 1:23pm ET
60.22
BATS BZX Real-Time Price
As of 1:23pm ET
 +1.39 / +2.36%
Today’s Change
52.83
Today|||52-Week Range
66.41
+7.02%
Year-to-Date
Q1 Earnings Surprise Well in Cards: Healthcare ETFs to Buy
12:05pm / Zacks.com - Paid Partner Content
US Stocks Edge Higher on Monday
Apr 16 / GuruFocus News - Paid Partner Content
What's in the Cards for Glaxo (GSK) This Earnings Season?
Apr 20 / Zacks.com - Paid Partner Content
Bristol-Myers Reports Positive Data in NSCLC Trial on Opdivo
Apr 16 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR
Apr 20 / Zacks.com - Paid Partner Content
Merck's Keytruda Reduces Death Risk in Melanoma Patients
Apr 16 / Zacks.com - Paid Partner Content
Lilly (LLY) to Report Q1 Earnings: What's in the Cards?
Apr 20 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: P&G Hikes Dividend; Boeing, American Airlines Ink $12B Deal
Apr 13 / Zacks.com - Paid Partner Content
J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?
Apr 20 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVS to Buy AveXis, PFE & ABBV's Drugs Succeed in Phase III
Apr 13 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Gets Priority Review for Lung Cancer
Apr 19 / Zacks.com - Paid Partner Content
Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings?
Apr 13 / Zacks.com - Paid Partner Content
Gillespie Robinson & Grimm Inc Buys Goldman Sachs Group Inc, Anadarko Petroleum Corp,...
Apr 19 / GuruFocus News - Paid Partner Content
Nektar Starts Phase I/II Combo for Advanced Solid Tumors
Apr 12 / Zacks.com - Paid Partner Content
Procter & Gamble Down Despite Earnings Beat
Apr 19 / GuruFocus News - Paid Partner Content
Pfizer's Kidney Cancer Drug Misses Endpoint in Phase III
Apr 11 / Zacks.com - Paid Partner Content
Merck's Keytruda Betters Survival in Lung Cancer Combo Study
Apr 17 / Zacks.com - Paid Partner Content
vTv Therapeutics Crashes on Alzheimer's Drug Study Failure
Apr 10 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Down as Merck NSCLC Study Fares Better
Apr 17 / Zacks.com - Paid Partner Content
Merck's Keytruda Offers Survival Benefit in Lung Cancer Study
Apr 10 / Zacks.com - Paid Partner Content
J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance
Apr 17 / Zacks.com - Paid Partner Content
NewLink Shares Plunge After Incyte & Merck's Study Fails
Apr 09 / Zacks.com - Paid Partner Content
Company News For Apr 17, 2018
Apr 17 / Zacks.com - Paid Partner Content
Top Analyst Reports for Microsoft, Merck & Union Pacific
Apr 09 / Zacks.com - Paid Partner Content
US Market Indexes Close Higher on Monday
Apr 16 / GuruFocus News - Paid Partner Content
Incyte's Epacadostat Fails in Melanoma Study, Shares Plunge
Apr 09 / Zacks.com - Paid Partner Content
Stop the market! I want to get off! Volatility is back
Apr 16 / CNNMoney.com
Trump isn't as pro-business as he claims
Mar 30 / CNNMoney.com